CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 22.10
-1.40 (-5.96%)
Jun 17, 2025, 2:46 PM GMT+1
CRISM Therapeutics Revenue
In the year 2024, CRISM Therapeutics had annual revenue of 25.00K GBP, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
307.17
Revenue / Employee
6.25K
Employees
4
Market Cap
7.68M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
CRISM Therapeutics News
- 5 weeks ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader